Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,772 total articles
SPAR Group, Inc. announced its financial guidance for fiscal year 2026, projecting net sales between $143 million and $151 million, and gross margins improving to 20.5%-22.5%. The company highlighted a favorable shift towards higher-margin core merchandising services, cost reductions, ongoing AI implementation for efficiency, and recent capital rai…
Fortress Biotech announced its full year 2025 financial results, highlighted by FDA approval of ZYCUBO® to treat Menkes disease, the sale of a Rare Pediatric Disease Priority Review Voucher for $205 million, and the acquisition of subsidiary Checkpoint Therapeutics by Sun Pharma which established a long-term royalty stream. The company showed impro…
Oculis Holding AG announced that the European Medicines Agency granted Priority Medicines (PRIME) designation to its neuroprotective candidate Privosegtor for optic neuritis (ON), following a prior FDA Breakthrough Therapy designation. Supported by positive Phase 2 trial results demonstrating significant improvements in visual function and neuropro…
Workhorse Group Inc. announced its fourth quarter and full year 2025 financial results, marking its first earnings report after merging with Motiv Electric Trucks. The company reported a 64% revenue increase in Q4 and a 201% rise for the full year, driven by vehicle deliveries and product lineup expansion. Workhorse is targeting $20 million in annu…
Nano Dimension Ltd. announced its financial results for Q4 and full year 2025, highlighting a 77.3% year-over-year revenue increase to $102.4 million driven partly by the acquisition of Markforged. Despite revenue growth and improved adjusted gross margins, the company reported a net loss of $100.4 million for the year. Cost reduction efforts are u…
ORIC Pharmaceuticals announced the selection of 400 mg once daily rinzimetostat (ORIC-944) in combination with darolutamide as the recommended Phase 3 dose (RP3D) for the Himalayas-1 global Phase 3 registrational trial in post-abiraterone metastatic castration-resistant prostate cancer (mCRPC). Phase 1b data show favorable safety and promising effi…
authID Inc. reported its financial results for Q4 and full year 2025 showing revenue growth but increased net losses. Total revenue doubled in the year to $2.0 million, though net loss increased to $17.9 million. The company highlighted significant new contracts and pilot deployments with global retailers, financial institutions, and technology par…
TOMI Environmental Solutions, Inc. announced its financial results for the year ended December 31, 2025. Despite a 27% decline in net sales due primarily to deferred capital expenditures amid economic uncertainty, the company improved its operating loss compared to 2024. TOMI continued to expand its global market presence, secured notable governmen…
Barfresh Food Group Inc. announced record revenue for 2025 of $14.2 million, driven by the acquisition of Arps Dairy and expanded school penetration. The company provided optimistic 2026 guidance with expected revenue between $28 million and $32 million, reflecting nearly 100% growth year-over-year. Barfresh secured $7.5 million in convertible note…
Rigetti Computing announced the sale and shipment of its 9-qubit Novera quantum processing unit (QPU) to the University of Saskatchewan, marking the establishment of USask's first quantum computing system. The system will be managed by the university's Centre for Quantum Topology and its Applications and aims to support innovative research in quant…
Dave & Buster’s Entertainment, Inc. announced its fourth quarter and fiscal year 2025 financial results, showing slight declines in revenue and comparable store sales, alongside significant net and adjusted net losses for both periods. The company experienced impacts from adverse weather and underperformance at some locations, resulting in impairme…
InspireMD, Inc., developer of the CGuard Prime carotid stent system, announced its participation in the 25th Annual Needham Virtual Healthcare Conference with a presentation scheduled for April 14th. The event will be webcast live and archived on InspireMD's corporate website.
nCino, Inc., a leading provider of intelligent banking solutions, reported strong financial results for the fourth quarter and fiscal year 2026, exceeding all financial guidance metrics. The company achieved record annual contract value (ACV) of $602.4 million, up 17% year-over-year, and a fiscal 2026 ACV net retention rate of 112%. Total revenues …
Howard Hughes Holdings announced that its 2026 Annual Shareholder Meeting will be held on September 17 in New York City, delayed from the original June date. The meeting will feature presentations on the upcoming acquisition of Vantage Group Holdings, expected to close in Q2, aiming to combine insurance expertise with Pershing Square's investment c…
KANZHUN LIMITED (BOSS Zhipin) announced the continuation of its share repurchase program, having spent approximately RMB34.5 million to buy back 744,334 shares on March 30, 2026. Total repurchases for the year so far exceed RMB576 million, demonstrating the company's focus on enhancing shareholder value.
SurgePays, Inc., a fintech and wireless point of sale company serving subprime and underserved consumers, announced it will report its financial results for Q4 and full year 2025 on April 14, 2026, with a scheduled conference call and webcast for investors.
Aware, Inc. announced its Intelligent Liveness biometric authentication system performed exceptionally well in the U.S. Department of Homeland Security's Remote Identity Validation Rally. The system achieved zero successful attacks in the active liveness test, ranked highly for user satisfaction and speed, demonstrating robust security without sacr…
Riverview Bancorp declared a quarterly cash dividend of $0.02 per share, unchanged from the previous quarter. The dividend will be paid on April 24, 2026, to shareholders of record as of April 13, 2026. The company operates as a regional community bank with assets of $1.51 billion and a focus on commercial, business, and retail clients primarily in…
Brookfield Business Corporation has filed its 2025 annual report with the SEC and Canadian securities authorities, including audited financial statements. The company finalized a corporate simplification by exchanging various partnership units for newly issued Class A shares, which will begin trading on the NYSE and TSX under the ticker BBUC starti…
Ellomay Capital Ltd. has published the financial statements of Dorad Energy Ltd. for the year ended December 31, 2025. Ellomay holds an indirect 16.9% stake in Dorad through Ellomay Luzon Energy. Dorad reported revenues of approximately NIS 2.65 billion and an operating profit of NIS 385 million for 2025. The results were impacted by seasonal elect…
Data Storage Corporation announced the postponement of its fiscal year 2025 investor conference call to allow more time to complete its year-end audit. The audit complexity stems from significant transactions including the sale of its CloudFirst subsidiary, warrant settlements, and a tender offer. A new date for the earnings call will be announced …
HeartCore Enterprises, Inc., a Tokyo-based IPO consulting services company listed on Nasdaq (HTCR), announced its full year 2025 results. The company reported revenues of $9.0 million, gross profit of $3.2 million, and net income of $5.5 million compared to a net loss last year. The positive net income was primarily due to gains from the divestitur…
Cognition Therapeutics announced progress in developing their lead candidate, Zervimesine (CT1812), for neurodegenerative diseases. Positive Phase 2 SHIMMER trial results support advancing the drug to late-stage trials for dementia with Lewy bodies (DLB) psychosis. The ongoing fully funded Phase 2 START trial in mild cognitive impairment and early …
Tarsus Pharmaceuticals has dosed the first participant in its Phase 2 Calliope trial evaluating TP-05 (lotilaner), an investigational oral systemic therapy aimed at preventing Lyme disease by killing infected ticks before transmission. The randomized, placebo-controlled trial will enroll approximately 700 adults at risk across endemic U.S. regions,…
Bel Fuse Inc. announced a strategic organizational realignment from a product-centric to an end-market-centric structure, consolidating its business units into two focused divisions: Aerospace, Defense & Rugged Solutions and Industrial Technology & Data Solutions. This restructuring is intended to sharpen market focus, accelerate innovation, and en…
